MSH Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
MSH Capital Advisors's LLY Position: Q2 2026 in Review
MSH Capital Advisors increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $354K and bringing the position to 1,685 shares worth $2.02M. The position accounts for 0.35% of the portfolio, ranked #70.
MSH Capital Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- MSH Capital Advisors held 1,685 shares of Eli Lilly worth $2.02M as of Q2 2026.
- MSH Capital Advisors bought 346 Eli Lilly shares in Q2 2026, an estimated $354K.
- Eli Lilly made up 0.35% of MSH Capital Advisors's portfolio in Q2 2026, its #70 holding.
- MSH Capital Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.